Vulcan Value Partners’ Thoughts on Medpace Holdings (MEDP)

17 hours ago 1

Soumya Eswaran

Fri, January 23, 2026 astatine 7:34 AM CST 5 min read

Investment absorption company Vulcan Value Partners recently released its fourth-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. All the strategies of Vulcan Value Partners delivered affirmative results successful the year. The Large Cap Composite (Net) returned -1.5% successful Q4 and 7.9% YTD, the Small Cap Composite (Net) gained 3.2% successful Q4 and 9.5% YTD, The Focus Composite (Net) retuned 0.1% successful Q4 and 7.1% YTD, Focus Plus Composite (Net) returned 0.1% successful Q4 and 6.2% YTD and the All-Cap Composite (Net) returned 1.3% successful Q4 and 10.7% YTD. Despite overvalued markets, the steadfast improved its price-to-value ratios portion inactive achieving affirmative returns, prioritizing information and semipermanent gains implicit short-term performance. This concern echoes the precocious 1990s dot-com bubble, wherever hype and precocious valuations led to a crash, and today’s AI disruptions look to reflector that pattern, with investors risking overpaying for promising businesses. The steadfast is addressing specified situations by sticking to its concern discipline. For much accusation connected the firm’s champion picks successful 2025, delight cheque its apical 5 holdings. In addition, delight cheque the firm’s apical 5 holdings to cognize its champion picks successful 2025.

In its fourth-quarter 2025 capitalist letter, Vulcan Value Partners highlighted Medpace Holdings, Inc. (NASDAQ:MEDP). Medpace Holdings, Inc. (NASDAQ:MEDP) is simply a healthcare institution that offers objective research-based cause and aesculapian instrumentality improvement services. Medpace Holdings, Inc. (NASDAQ:MEDP) shares traded betwixt $250.05 and $628.92 implicit the past 52 weeks. On January 22, 2026, Medpace Holdings, Inc. (NASDAQ:MEDP) banal closed astatine $606.27 per share. One-month instrumentality of Medpace Holdings, Inc. (NASDAQ:MEDP) was 6.82%, and its shares gained 0.18% of their worth implicit the past 3 months. Medpace Holdings, Inc. (NASDAQ:MEDP) has a marketplace capitalization of astir $17.078 billion.

Vulcan Value Partners stated the pursuing regarding Medpace Holdings, Inc. (NASDAQ:MEDP) successful its 4th fourth 2025 capitalist letter:

"It is unthinkable to person a portfolio with a weighted mean terms to worth ratio successful the mid-50’s successful today’s environment. The system is steadfast and resilient. Interest rates are headed down. The bulk of our MVP database is overvalued, arsenic is usually the case. The broader market, dominated by precise ample headdress companies, is surely not inexpensive connected immoderate metric. Yet, we person a portfolio trading astatine a ample discount to our estimation of intrinsic value. Could our values beryllium wrong? Yes, but our way record, supported by comps, suggests that we are reasonably bully astatine valuation. We usage the aforesaid mathematics for each institution we value. The aforesaid mathematics that says our discounted companies are discounted is the aforesaid mathematics that says the overvalued companies we bash not ain truly are overvalued.